Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

NCT00736450 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

37

Enrollment

OTHER

Sponsor class

Stopped Manufacturer is no longer making the drug.

Conditions

Contiguous Stage II Adult Diffuse Large Cell Lymphoma
Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma
Stage I Adult Diffuse Large Cell Lymphoma
Stage III Adult Diffuse Large Cell Lymphoma
Stage IV Adult Diffuse Large Cell Lymphoma

Interventions

BIOLOGICAL: oblimersen sodium
BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: vincristine sulfate
DRUG: prednisone
PROCEDURE: biopsy
GENETIC: microarray analysis
OTHER: immunohistochemistry staining method
GENETIC: gene expression analysis
GENETIC: cytogenetic analysis

Sponsor

University of Nebraska

Collaborators

[object Object]
[object Object]